Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder:: observational follow-up study

被引:286
|
作者
Tiihonen, Jari [1 ]
Wahlbeck, Kristian
Lonnqvist, Jouko
Klaukka, Timo
Ioannidis, John P. A.
Volavka, Jan
Haukka, Jari
机构
[1] Univ Kuopio, Niuvanniemi Hosp, Dept Forens Psychiat, FIN-70240 Kuopio, Finland
[2] Natl Res & Dev Ctr Welf & Hlth STAKES, Helsinki, Finland
[3] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland
[4] Social Insurance Inst, Helsinki, Finland
[5] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece
[6] NYU, New York, NY USA
来源
BRITISH MEDICAL JOURNAL | 2006年 / 333卷 / 7561期
关键词
D O I
10.1136/bmj.38881.382755.2F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To study the association between prescribed antipsychotic drugs and outcome in schizophrenia or schizoaffective disorder in the community. Design Prospective cohort study using national central registers. Setting Community care in Finland. Participants Nationwide cohort of 2230 consecutive adults hospitalised in Finland for the first time because of schizophrenia or schizoaffective disorder, January 1995 to December 2001. Main outcome measures Rates of discontinuation of drugs (all causes), rates of rehospitalisation, and mortality associated with monotherapy with the 10 most commonly used antipsychotic drugs. Multivariate models and propensity score methods were used to adjust estimates of effectiveness. Results Initial use of clozapine (adjusted relative risk 0.17, 95% confidence interval 0.10 to 0.29), perphenazine depot (0.24, 0.13 to 0.47), and olanzapine (0.35, 0.18 to 0.71) were associated with the lowest rates of discontinuation for any reason when compared with oral haloperidol. During an average follow-up of 3.6 years, 4640 cases of rehospitalisation were recorded. Current use of perphenazine depot (0.32, 0.22 to 0.49), olanzapine (0.54, 0.41 to 0.71), and clozapine (0.64, 0.48 to 0.85) were associated with the lowest risk of rehospitalisation. Use of haloperidol was associated with a poor outcome among women. Mortality was markedly raised in patients not taking antipsychotics (12.3, 6.0 to 24.1) and the risk of suicide was high (37.4, 5.1 to 276). Conclusions The effectiveness of first and second generation antipsychotics varies greatly in the community. Patients treated with perphenazine depot, clozapine, or olanzapine have a substantially lower risk of rehospitalisation or discontinuation (for any reason) of their initial treatment than do patients treated with haloperidol. Excess mortality is seen mostly in patients not using antipsychotic drugs.
引用
收藏
页码:224 / 227
页数:4
相关论文
共 50 条
  • [31] 20-Year Nationwide Follow-Up Study on Antipsychotic Treatment, Re-Hospitalization, and Mortality in First-Episode Schizophrenia (FIN20 Study)
    Tiihonen, Jari
    Tanskanen, Antti
    Taipale, Heidi
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S604 - S605
  • [32] Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
    Moilanen, J.
    Haapea, M.
    Miettunen, J.
    Jaaskelainen, E.
    Veijola, J.
    Isohanni, M.
    Koponen, H.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28 (01) : 53 - 58
  • [33] Depressive Disorder in Thyroid Cancer Patients after Thyroidectomy: A Longitudinal Follow-up Study Using a National Cohort
    Choi, Hyo Geun
    Park, Bumjung
    Ji, Yong Bae
    Tae, Kyung
    Song, Chang Myeon
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (02) : 239 - 245
  • [34] STRUCTURAL BRAIN CORRELATES OF SENSORIMOTOR GATING IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS: A 6 YEAR FOLLOW-UP STUDY OF INITIALLY ANTIPSYCHOTIC NAIVE, FIRST-EPISODE SCHIZOPHRENIA PATIENTS
    Hammer, Trine Bjorg
    Oranje, B.
    Skimminge, A.
    Ebdrup, Bjorn H.
    Bro, H.
    Siebner, H. R.
    Fagerlund, B.
    Glenthoj, B. Y.
    Baare, W.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 166 - 167
  • [35] The role of geography and distance on physician follow-up after a first hospitalization with a diagnosis of a schizophrenia spectrum disorder: A retrospective population-based cohort study in Ontario, Canada
    Rotenberg, Martin
    Gozdyra, Peter
    Anderson, Kelly K.
    Kurdyak, Paul
    [J]. PLOS ONE, 2023, 18 (06):
  • [36] Occupational outcome of patients with schizophrenia after first request for disability status: A 2-year follow-up study
    Verdoux, H.
    Goumilloux, R.
    Monello, F.
    Cougnard, A.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2010, 36 (06): : 484 - 490
  • [37] Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study
    Taipale, Heidi
    Tanskanen, Antti
    Correll, Christoph U.
    Tiihonen, Jari
    [J]. LANCET PSYCHIATRY, 2022, 9 (04): : 271 - 279
  • [38] Outpatient Follow-Up Visit after Hospital Discharge Lowers Risk of Rehospitalization in Patients with Schizophrenia: A Nationwide Population-Based Study
    Lee, Seung Yup
    Kim, Kyoung Hoon
    Kim, Tae
    Kim, Sun Min
    Kim, Jong-Woo
    Han, Changsu
    Song, Ji Young
    Paik, Jong-Woo
    [J]. PSYCHIATRY INVESTIGATION, 2015, 12 (04) : 425 - 433
  • [39] Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study
    Ucok, Alp
    Kara, Ilayda Arjen
    [J]. SCHIZOPHRENIA RESEARCH, 2020, 225 : 31 - 38
  • [40] Observational Follow-up Study on a Cohort of Children with Severe Pneumonia after Discharge from a Day-care Clinic in Dhaka, Bangladesh
    Ashraf, Hasan
    Alam, Nur H.
    Chisti, Mohammod J.
    Salam, Mohammed A.
    Ahmed, Tahmeed
    Gyr, Niklaus
    [J]. JOURNAL OF HEALTH POPULATION AND NUTRITION, 2014, 32 (02) : 183 - 189